人类肺泡包虫病:停止阿苯达唑治疗的后果——附两例报告。

Q3 Medicine
Przeglad epidemiologiczny Pub Date : 2025-10-03 Epub Date: 2025-07-04 DOI:10.32394/pe/207616
Jacek Czepiel, Jeremiasz Bik, Anna Królikowska, Martyna Lara, Mateusz Myśliwiec, Marcin Poręba, Grażyna Biesiada, Monika Bociaga-Jasik
{"title":"人类肺泡包虫病:停止阿苯达唑治疗的后果——附两例报告。","authors":"Jacek Czepiel, Jeremiasz Bik, Anna Królikowska, Martyna Lara, Mateusz Myśliwiec, Marcin Poręba, Grażyna Biesiada, Monika Bociaga-Jasik","doi":"10.32394/pe/207616","DOIUrl":null,"url":null,"abstract":"<p><p>Alveolar echinococcosis (AE) is a rare and life-threatening parasitic infection caused by Echinococcus multilocularis. Nonspecific symptoms along with a lowered awareness of the disease among physicians often result in delayed diagnoses and subsequently limiting therapeutic options. Treatment of AE includes surgical resection with wide margins of healthy tissue combined with pharmacotherapy and close monitoring for recurrence. This paper presents two cases of patients who interrupted albendazole therapy administered after surgical removal of parasitic lesions. Both cases demonstrate that discontinuing albendazole therapy after non-radical echinococcal removal can lead to disease progression and life-threatening complications. Additionally, the report highlights socioeconomic challenges such as therapy accessibility, treatment costs, and patient education which can influence adherence to medical recommendations and treatment outcomes.</p>","PeriodicalId":20777,"journal":{"name":"Przeglad epidemiologiczny","volume":"79 2","pages":"169-177"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Human alveolar echinococcosis: consequences of discontinuation of albendazole treatment - a report of two cases.\",\"authors\":\"Jacek Czepiel, Jeremiasz Bik, Anna Królikowska, Martyna Lara, Mateusz Myśliwiec, Marcin Poręba, Grażyna Biesiada, Monika Bociaga-Jasik\",\"doi\":\"10.32394/pe/207616\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Alveolar echinococcosis (AE) is a rare and life-threatening parasitic infection caused by Echinococcus multilocularis. Nonspecific symptoms along with a lowered awareness of the disease among physicians often result in delayed diagnoses and subsequently limiting therapeutic options. Treatment of AE includes surgical resection with wide margins of healthy tissue combined with pharmacotherapy and close monitoring for recurrence. This paper presents two cases of patients who interrupted albendazole therapy administered after surgical removal of parasitic lesions. Both cases demonstrate that discontinuing albendazole therapy after non-radical echinococcal removal can lead to disease progression and life-threatening complications. Additionally, the report highlights socioeconomic challenges such as therapy accessibility, treatment costs, and patient education which can influence adherence to medical recommendations and treatment outcomes.</p>\",\"PeriodicalId\":20777,\"journal\":{\"name\":\"Przeglad epidemiologiczny\",\"volume\":\"79 2\",\"pages\":\"169-177\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Przeglad epidemiologiczny\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32394/pe/207616\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad epidemiologiczny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32394/pe/207616","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

肺泡棘球蚴病(AE)是由多房棘球蚴引起的一种罕见且危及生命的寄生虫感染。非特异性症状以及医生对疾病认识的降低往往导致诊断延误,从而限制了治疗选择。AE的治疗包括手术切除大切缘的健康组织,结合药物治疗和密切监测复发。本文介绍了两例患者在手术切除寄生虫病变后中断阿苯达唑治疗。这两个病例表明,非根治性棘球蚴清除后停止阿苯达唑治疗可导致疾病进展和危及生命的并发症。此外,该报告强调了社会经济挑战,如治疗可及性、治疗费用和患者教育,这些都可能影响对医疗建议和治疗结果的依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Human alveolar echinococcosis: consequences of discontinuation of albendazole treatment - a report of two cases.

Alveolar echinococcosis (AE) is a rare and life-threatening parasitic infection caused by Echinococcus multilocularis. Nonspecific symptoms along with a lowered awareness of the disease among physicians often result in delayed diagnoses and subsequently limiting therapeutic options. Treatment of AE includes surgical resection with wide margins of healthy tissue combined with pharmacotherapy and close monitoring for recurrence. This paper presents two cases of patients who interrupted albendazole therapy administered after surgical removal of parasitic lesions. Both cases demonstrate that discontinuing albendazole therapy after non-radical echinococcal removal can lead to disease progression and life-threatening complications. Additionally, the report highlights socioeconomic challenges such as therapy accessibility, treatment costs, and patient education which can influence adherence to medical recommendations and treatment outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Przeglad epidemiologiczny
Przeglad epidemiologiczny Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
64
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信